Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation

Online download statistics by month:

Online download statistics by month: June 2021 to March 2024

	Abstract	Full	Pdf
Jun 2021	35	17	15
Jul 2021	4	1	1
Aug 2021	3	2	0
Sep 2021	8	2	0
Oct 2021	139	0	0
Nov 2021	212	1	1
Dec 2021	280	0	3
Jan 2022	227	3	0
Feb 2022	200	1	1
Mar 2022	200	0	0
Apr 2022	201	0	0
May 2022	216	3	2
Jun 2022	210	5	1
Jul 2022	207	4	0
Aug 2022	236	3	2
Sep 2022	219	4	0
Oct 2022	182	3	0
Nov 2022	184	0	0
Dec 2022	172	0	0
Jan 2023	161	3	0
Feb 2023	200	7	1
Mar 2023	146	2	1
Apr 2023	351	5	3
May 2023	545	5	4
Jun 2023	504	2	1
Jul 2023	86	1	2
Aug 2023	174	6	2
Sep 2023	86	3	2
Oct 2023	68	2	1
Nov 2023	45	1	0
Dec 2023	66	0	1
Jan 2024	58	0	0
Feb 2024	106	1	2
Mar 2024	55	4	3
Total	5786	91	49